Nicole Balmaceda, MD
Hematology & Oncology Physician · Houston, TX
Nicole Balmaceda, MD is a hematology & oncology physician with a practice address in Houston, Texas, and NPI 1740846237, issued on May 10, 2019. Check the license (Texas V6551, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Nicole Balmaceda
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- V6551 TX
94-09835 KS
Self-reported in NPPES; status is on the state search - Practice location
- 1515 Holcombe Blvd, Houston, TX 77030
- Phone
- (713) 792-6161
- Enumerated
- May 10, 2019
- Record last updated
- Jul 23, 2025
- Medicare enrollment
- Enrolled (PECOS I20250806001085); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 922 in Texas → Look up another NPI →
Also registered at 1515 Holcombe Blvd
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Ashley Aaroe, MDNeurology Physician1902295793
- Linda Abad, PA-CPhysician Assistant1063928240
- Cynthia Abarado, RN, GNPGerontology Nurse Practitioner1851471049
- Hussein Abbas, MD, PHDInternal Medicine Physician1609220532
- James Abbruzzese, M.D.Medical Oncology Physician1134233224
- Karim Abdeldaem, MDEmergency Medicine Physician1558056200
Verify Nicole Balmaceda in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license V6551Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
98% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
21 Medicare Part D claims, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 0% of claims.
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $384.77
3 payments; by number, the most common kind was food and beverage; the largest payer was Array Biopharma Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Physicians Referral ServiceHouston, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Nicole Balmaceda among 922 hematology & oncology physician records in Texas
Nicole Balmaceda, MD is one of 922 hematology & oncology physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2019, is newer than 93% of them.
- NPI issued2019 · 93% of these records are older, 4% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 75% of these records are
- Graduated2019 · median 2004 among the 691 with a school on file
- Record last updated2025 · 51% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Texas
There are 922 hematology & oncology physician records in Texas.
All 922 in Texas → Every provider in Houston → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Ana AparicioHouston, TX 770301720033657
- Ahmed Eid, M.D.Houston, TX 770301649227406
- Susan Escudier, M.D.Houston, TX 770301831138221
- Lawrence Foote, M.D.Houston, TX 770301295777456
- Charles Geyer, MDHouston, TX 770301891795001
- Linus Ho, M.D., PH.D.Houston, TX 770301376525980
- Kevin Hude, M.D.Houston, TX 770301114996303
- Charles Manner, M. D.Houston, TX 770301760443782
Common questions
What is Nicole Balmaceda, MD's NPI number?
Nicole Balmaceda, MD's National Provider Identifier (NPI) is 1740846237, issued on May 10, 2019. An NPI identifies a provider in billing; it is not a license.
Where is Nicole Balmaceda, MD located?
The NPPES record lists a practice address at 1515 Holcombe Blvd, Houston, TX, 77030. Phone: (713) 792-6161. Providers update this record themselves, so call before visiting.
How can I verify Nicole Balmaceda, MD's license?
NPPES lists Texas license number V6551, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Nicole Balmaceda, MD prescribe under Medicare Part D?
In 2024, Nicole Balmaceda, MD had 21 Medicare Part D claims; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.